RecruitingAcute Ischemic StrokeAtrial Fibrillation
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will determine whether early, comprehensive, rhythm control therapy prevents adverse cardiovascular outcome in patients with acute ischemic stroke and atrial fibrillation compared to usual care.
Sponsor: Universitätsklinikum Hamburg-Eppendorf
You may qualify if…
- ✓ Acute ischemic stroke in the previous four weeks, diagnosed by imaging (CT or MRI) or clinical diagnosis
- ✓ Possibility to start the trial treatment within 4 weeks after stroke, and as soon as clinically justifiable
- ✓ AF first detected ≤1 year prior to randomization
- ✓ Informed consent
You may not qualify if…
- ✕ End-stage cancer or life-expectancy \< 12 months due to other advanced co-morbid illness
- ✕ Prior AF ablation or surgical therapy of AF
- ✕ Patients not suitable for rhythm control of AF due to cardiac conditions
Source: ClinicalTrials.gov · NCT05293080 · last updated 2026-05-18